Company Number: 13836000

Analysis Date: 2025-07-20 13:31 UTC

1. Executive Summary
   CyberPT Limited is a nascent private limited company operating within the "Other human health activities" industry (SIC 86900). It maintains a modest financial profile with positive net current assets and shareholder funds, indicating a stable foundation. Strategically, the company is positioned to leverage its niche in human health services but remains in an early developmental phase with limited scale and operational complexity.

2. Strategic Assets

• Focused Industry Niche: Operating in a specialized segment of human health activities offers potential for targeted service offerings and less direct competition than broader healthcare markets.
• Strong Shareholder Control: With a single controlling shareholder (Glyn Amos) holding 75-100% ownership and voting rights, decision-making agility and alignment of strategic vision are ensured.
• Positive Working Capital: The company reported net current assets of £534 at year-end 2024, signaling adequate short-term liquidity to support operational needs and incremental growth.
• Tangible Fixed Assets Growth: Increased investment in tangible assets (£878 net book value as of 2024) suggests capital allocation toward capacity building or service delivery infrastructure.

3. Growth Opportunities

• Market Development: CyberPT can deepen its service portfolio within human health activities, potentially expanding into adjacent services or specialized therapeutic areas to capture unmet needs.
• Scaling Operations: With current operations supported by a single employee, there is significant upside in scaling human resources and operational infrastructure to increase service capacity and geographic reach.
• Technology Integration: Leveraging digital health technologies or telehealth solutions could differentiate CyberPT’s offerings, improve client engagement, and enhance operational efficiency.
• Strategic Partnerships: Forming alliances with healthcare providers, insurers, or community organizations could accelerate market penetration and brand recognition.

4. Strategic Risks

• Limited Financial Scale and Resources: The company’s low cash reserves (£4,010) and relatively small equity base may constrain investment capacity and limit resilience against market or operational shocks.
• Dependence on Single Leadership: Heavy reliance on one director and controlling shareholder poses governance and continuity risks, especially if expansion requires diverse expertise or additional capital.
• Regulatory Environment: Operating in the health sector entails compliance with strict regulations and evolving standards, which could increase operational complexity and costs.
• Market Visibility and Brand Development: As a new entrant, CyberPT may face challenges in establishing market presence and trust amid established competitors without significant marketing or reputational investment.